Navigation Links
Quantum Materials Corporation Supplies Tetrapod Quantum Dots to U.S. Government Researchers
Date:3/27/2013

CARSON CITY, Nev., March 27, 2013 /PRNewswire/ -- Quantum Materials Corporation (OTCQB:QTMM) has recently developed and delivered customized tetrapod QD samples for applications being developed by Department of Energy National Lab researchers. As one of the largest sponsors of US technical and military research, the DOE helps move innovative technologies into the commercial marketplace creating new jobs and future industries. QMC has also agreed to supply customized tetrapod quantum dots to a U.S. government defense related agency in support of a nano-biological project.

(Logo: http://photos.prnewswire.com/prnh/20121120/DA16554LOGO)

More than 110 science-related Nobel Prizes have been awarded to DOE-associated researchers. Department of Energy National Labs, Energy Innovation Hubs and Technology Centers are developing quantum dot and other nanoscale applications including solar photovoltaics, batteries, biofuels, physics and in biological sciences. An example of this is work at Los Alamos National Lab (LANL) exploring quantum dot- fluorescent proteins (QD-FP) in devices utilizing pH-sensitive fluorescent protein acceptors to produce long-lived sensors for biological imaging. LANL's use of quantum dots for precise cellular imaging produces valuable data for the hopeful cure or treatment of many diseases and conditions. 

Quantum Materials Corporation believes its technology meets three NNI National Signature Initiatives objectives:  new advanced materials (tetrapod quantum dots), mass production (continuous flow process) and nanomanufacturing (roll-to-roll printing). Stephen Squires , Quantum Materials Corporation CEO commented, "The many DOE National Labs are in the forefront of quantum dot research and we welcome the opportunity to collaborate with them. QMC has enabling technologies to help fulfill NNI National Signature Initiatives years ahead of forecasts, advancing the nation's research rapidly while perhaps saving the U.S. Government millions that can be redirected to application development."

QMC currently offers high-brightness Cd-based and ecological Cadmium-free non-heavy metal tetrapod QD and can synthesize many Group II-VI inorganic mono or hybrid tetrapod quantum dots. QMC intends to build out its quantum dot production facilities in the U.S. with full commercial production expected in the fourth quarter of 2013.

About Quantum Materials Corporation, Inc. and Solterra Renewable Technologies, Inc.

QUANTUM MATERIALS CORPORATION, INC has a steadfast vision that advanced technology is the solution to global issues related to cost, efficiency and increasing energy usage. Quantum dot semiconductors enable a new level of performance in a wide array of established consumer and industrial products, including low cost flexible solar cells, low power lighting and displays and biomedical diagnostic applications. Quantum Materials Corporation intends to invigorate these markets through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products. (http://www.qmcdots.com)

SOLTERRA RENEWABLE TECHNOLOGIES, INC is singularly positioned to lead the development of truly sustainable and cost-effective solar technology by introducing a new dimension of cost reduction by replacing silicon wafer-based solar cells with low-cost, highly efficient Quantum Dot-based solar cells.
(http://solterrarenewable.com)

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at http://www.sec.gov/ or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

Contact:
Art Lamstein
Director of Marketing
Quantum Materials Corporation
Solterra Renewable Technologies
artlamstein@QMCdots.com


'/>"/>
SOURCE Quantum Materials Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Block Engineering Partners with SKAE and Pembroke for Quantum Cascade Laser Instrument Sales
2. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
3. SAFC Expands PharmaGrade Raw Materials Portfolio to Meet Growing Demand; Expects to Double PharmaGrade Portfolio in 2013
4. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
5. Olympus Biotech International Ltd and BonAlive Biomaterials Ltd Announce Distribution Agreement
6. Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries
7. SAFC Expands PharmaGrade Raw Materials Portfolio for Biopharmaceutical Manufacturing
8. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
9. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
10. Innophos To Present At 2012 KeyBanc Capital Markets Basic Materials & Packaging Conference
11. Verathon, maker of BladderScan bladder volume ultrasound, provides new, free CAUTI prevention educational materials online to help nurses and infection preventionists reduce catheter-associated urinary tract infections.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... focused on the development of oral drug delivery systems, ... with the U.S. Food and Drug Administration (FDA) regarding ... At the meeting, the FDA ... of ORMD-0801, would be a Biologics License Application (BLA).  ...
Breaking Medicine Technology:
(Date:9/20/2017)... NC (PRWEB) , ... September 20, 2017 , ... ... Transformation and Centers of Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, ... designed presence offers quick and easy access to essential information that offers a ...
(Date:9/20/2017)... GLENDALE, Calif. (PRWEB) , ... September 20, 2017 ... ... 15th year of providing a voice for people who have kidney disease. The ... many writers to share their stories. Entrants needed to meet only one ...
(Date:9/20/2017)... ... 2017 , ... Mirror Mirror Beauty Boutique is excited to ... Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the afternoon will include live ... Boutique is Houston’s largest CoolSculpting provider, holding the prestigious title of ...
(Date:9/20/2017)... ... 20, 2017 , ... As part of The Garland Company, ... redesigned website. The new site – still located at http://www.garlandco.com – ... other industry users that Garland serves. , After an ambitious phase of industry ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going ... receiving positive feedback from customers trying the product for the first time, and others ... was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from ...
Breaking Medicine News(10 mins):